Revised forecast
Fiscal year ending March 2027 · Six months and full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Impairment loss of ¥426 million, provision for losses on closure of plants of ¥413 million, and total extraordinary losses of ¥839 million
| Item | Details |
|---|---|
| Net Sales | Not disclosed → Cumulative second-quarter results 37,200 / Full year 75,000（Cumulative second-quarter results 23.0% (year on year) / Full year 19.0% (year on year)） |
| Operating profit | Not disclosed → Cumulative second-quarter results 3,700 / Full year 8,200（Cumulative second-quarter results 139.7% (year on year) / Full year 99.9% (year on year)） |
| Ordinary income | Not disclosed → Cumulative second-quarter results 3,400 / Full year 8,100（Cumulative second-quarter results 91.4% (year on year) / Full year 56.9% (year on year)） |
| Profit attributable to owners of the parent | Not disclosed → Cumulative second-quarter results 2,400 / Full year 6,800（Cumulative second-quarter results 40.6% (year on year) / Full year 67.1% (year on year)） |
| Net income per share | Not disclosed → Cumulative second-quarter results 34.64 / Full year 98.66 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Six months and full year |
| Previous-period results | Fiscal year ended March 2026: net sales of ¥63,031 million, operating profit of ¥4,102 million, ordinary profit of ¥5,162 million, net income attributable to owners of the parent of ¥4,069 million, and net income per share of ¥58.51 |
| Details and amount of extraordinary loss | Impairment loss of ¥426 million, provision for losses on closure of plants of ¥413 million, and total extraordinary losses of ¥839 million |
| Dividend forecast revision | For the fiscal year ending March 2027, annual dividends of ¥32.00 per share are planned, comprising an interim dividend of ¥16.00 and a year-end dividend of ¥16.00. No information was provided on whether the forecast was revised. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Demand increased in Japan and overseas for semiconductor manufacturing equipment, placement machines, machine tools, robots and medical equipment, among other products. In Europe, the company benefited from a recovery in demand and the weaker yen, while in China, demand related to semiconductors and large-scale capital investment projects contributed to results. In addition to the effects of higher sales and production, the company cited measures including sales activities, new product development and production efficiency improvements.